{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:43:46Z","timestamp":1792593826519,"version":"4.5.0"},"reference-count":12,"publisher":"MyJove Corporation","issue":"224","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/69303","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:01:08Z","timestamp":1760137268000},"source":"Crossref","is-referenced-by-count":2,"title":["Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes"],"prefix":"10.3791","author":[{"given":"Shihori","family":"Kawano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Saegusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Masano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Shiozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Fujikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Toyohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1196\/annals.1444.011","type":"journal-article","article-title":"Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome","volume":"1142","author":"Sproule","year":"2008","unstructured":"Sproule, D. M., Kaufmann, P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci. 1142, 133-158 (2008).","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4161\/rna.2.2.1610","type":"journal-article","article-title":"Human mitochondrial diseases associated with tRNA wobble modification deficiency","volume":"2","author":"Kirino","year":"2005","unstructured":"Kirino, Y., Suzuki, T. Human mitochondrial diseases associated with tRNA wobble modification deficiency. RNA Biol. 2 (2), 41-44 (2005).","journal-title":"RNA Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00726-012-1414-8","type":"journal-article","article-title":"Role of taurine in the pathologies of MELAS and MERRF","volume":"46","author":"Shaffer","year":"2014","unstructured":"Shaffer, S. W., et al. Role of taurine in the pathologies of MELAS and MERRF. Amino Acids. 46, 47-56 (2014).","journal-title":"Amino Acids"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4062\/biomolther.2017.251","type":"journal-article","article-title":"Effects and mechanisms of taurine as a therapeutic agent","volume":"26","author":"Shaffer","year":"2018","unstructured":"Shaffer, S. W., Kim, H. W. Effects and mechanisms of taurine as a therapeutic agent. Biomol Ther. 26, 225-241 (2018).","journal-title":"Biomol Ther"},{"issue":"24","key":"ref5","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.2169\/internalmedicine.51.7529","type":"journal-article","article-title":"Taurine ameliorates impaired mitochondrial function and prevents stroke-like episodes in patients with MELAS","volume":"51","author":"Rikimaru","year":"2012","unstructured":"Rikimaru, M., et al. Taurine ameliorates impaired mitochondrial function and prevents stroke-like episodes in patients with MELAS. Intern Med. 51 (24), 3351-3357 (2012).","journal-title":"Intern Med"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/jnnp-2018-317964","type":"journal-article","article-title":"Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial","volume":"90","author":"Ohsawa","year":"2019","unstructured":"Ohsawa, Y., et al. Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial. J Neurol Neurosurg Psychiatry. 90 (5), 529-536 (2019).","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"e55678","DOI":"10.15252\/embr.202255678","type":"journal-article","article-title":"Modeling mitochondrial DNA diseases: from base editing to pluripotent stem-cell-derived organoids","volume":"24","author":"Tolle","year":"2023","unstructured":"Tolle, I., Tiranti, V., Prigione, A. Modeling mitochondrial DNA diseases: from base editing to pluripotent stem-cell-derived organoids. EMBO Rep. 24 (4), e55678 (2023).","journal-title":"EMBO Rep"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00125-012-2508-2","type":"journal-article","article-title":"Induced pluripotent stem cells generated from diabetic patients with mitochondrial DNA A3243G mutation","volume":"55","author":"Fujikura","year":"2012","unstructured":"Fujikura, J., et al. Induced pluripotent stem cells generated from diabetic patients with mitochondrial DNA A3243G mutation. Diabetologia. 55 (6), 1689-1698 (2012).","journal-title":"Diabetologia"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.stemcr.2019.08.011","type":"journal-article","article-title":"Pathological progression induced by the frontotemporal dementia-associated R406W tau mutation in patient-derived iPSCs","volume":"13","author":"Nakamura","year":"2019","unstructured":"Nakamura, M., et al. Pathological progression induced by the frontotemporal dementia-associated R406W tau mutation in patient-derived iPSCs. Stem Cell Rep. 13 (4), 684-699 (2019).","journal-title":"Stem Cell Rep"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.tcb.2024.12.001","type":"journal-article","article-title":"Emerging approaches to enhance human brain organoid physiology","volume":"35","author":"Pagliaro","year":"2025","unstructured":"Pagliaro, A., Artegiani, B., Hendriks, D. Emerging approaches to enhance human brain organoid physiology. Trends Cell Biol. 35 (6), 483-499 (2025).","journal-title":"Trends Cell Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.fob.2015.03.008","type":"journal-article","article-title":"Impaired respiratory function in MELAS-induced pluripotent stem cells with high heteroplasmy levels","volume":"5","author":"Kodaira","year":"2015","unstructured":"Kodaira, M., et al. Impaired respiratory function in MELAS-induced pluripotent stem cells with high heteroplasmy levels. FEBS Open Bio. 5, 219-225 (2015).","journal-title":"FEBS Open Bio"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"101921","DOI":"10.1016\/j.redox.2021.101921","type":"journal-article","article-title":"Taurine rescues mitochondria-related metabolic impairments in the patient-derived induced pluripotent stem cells and epithelial-mesenchymal transition in the retinal pigment epithelium","volume":"41","author":"Homma","year":"2021","unstructured":"Homma, K., et al. Taurine rescues mitochondria-related metabolic impairments in the patient-derived induced pluripotent stem cells and epithelial-mesenchymal transition in the retinal pigment epithelium. Redox Biol. 41, 101921 (2021).","journal-title":"Redox Biol"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/69303\/modeling-mitochondrial-disease-using-brain-organoids-focus-on","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:22:44Z","timestamp":1792592564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/69303\/modeling-mitochondrial-disease-using-brain-organoids-focus-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":12,"journal-issue":{"issue":"224","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3791\/69303","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]}}}